The agreement covers technology transfer, process development, scale-up, validation, commercial manufacturing, and long-term supply across multiple markets.
The latest updates include shopfloor, data, and warehouse management capabilities intended to improve operator guidance and traceability for individualized therapies.
Learn how oxygen-enriched biological treatment helps pharmaceutical manufacturers unlock up to 50% additional wastewater treatment capacity, improve oxygen transfer efficiency, and maximize the performance of existing wastewater treatment assets.
